Laurie has over a decade of experience in conducting and disseminating research in the area of prenatal substance use and infant outcomes. While in Minnesota she examined statewide prenatal substance use, the diagnosis of Fetal Alcohol Syndrome, and the design and evaluation of a randomized-control, treatment-group evaluation of a substance abuse treatment program for high-risk women. Since moving to Tennessee in 2012, Laurie has initiated the examination of prenatal opioid use and its effects on infants.